$15.31
2.20% yesterday
Nasdaq, Nov 25, 10:01 pm CET
ISIN
US6404911066
Symbol
NEOG

Neogen Corporation Stock price

$15.31
+1.50 10.86% 1M
+2.05 15.46% 6M
-4.80 23.87% YTD
-1.47 8.76% 1Y
-28.22 64.83% 3Y
-18.57 54.80% 5Y
-1.21 7.30% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.33 2.20%
ISIN
US6404911066
Symbol
NEOG
Sector

Key metrics

Market capitalization $3.32b
Enterprise Value $4.09b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 4.48
P/S ratio (TTM) P/S ratio 3.64
P/B ratio (TTM) P/B ratio 1.06
Revenue growth (TTM) Revenue growth -0.75%
Revenue (TTM) Revenue $912.20m
EBIT (operating result TTM) EBIT $58.84m
Free Cash Flow (TTM) Free Cash Flow $-125.42m
Cash position $120.48m
EPS (TTM) EPS $-0.11
P/E forward negative
P/S forward 3.54
EV/Sales forward 4.37
Short interest 10.28%
Show more

Is Neogen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Neogen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Neogen Corporation forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Neogen Corporation forecast:

Buy
67%
Hold
33%

Financial data from Neogen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
912 912
1% 1%
100%
- Direct Costs 480 480
5% 5%
53%
432 432
6% 6%
47%
- Selling and Administrative Expenses 235 235
13% 13%
26%
- Research and Development Expense 21 21
25% 25%
2%
177 177
9% 9%
19%
- Depreciation and Amortization 118 118
6% 6%
13%
EBIT (Operating Income) EBIT 59 59
16% 16%
6%
Net Profit -24 -24
11% 11%
-3%

In millions USD.

Don't miss a Thing! We will send you all news about Neogen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Neogen Corporation Stock News

Neutral
PRNewsWire
21 days ago
LANSING, Mich. , Nov. 5, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12.
Negative
Seeking Alpha
about 2 months ago
Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound.
Neutral
Seeking Alpha
about 2 months ago
Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good mo...
More Neogen Corporation News

Company Profile

Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety, Animal Safety, and Corporate and Eliminations. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation. The Animal Safety segment includes a line of consumable products marketed to veterinarians and animal health product distributors. The Corporate and eliminations segment refers to the corporate assets, including cash and cash equivalents, marketable securities, current and deferred tax accounts, and overhead expenses not allocated to specific business segments. The company was founded on June 30, 1981 and is headquartered in Lansing, MI.

Head office United States
CEO John Adent
Employees 2,917
Founded 1981
Website www.neogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today